Ask Warren

Cellid

299660 · KOSDAQ · ₩299660 · 셀리드

₩2,040▼ ₩85 (4.00%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • [Amended] Results of Securities Issuance (Voluntary Disclosure)[기재정정]증권발행결과(자율공시)

    Predicted impact: Low

    Oct 29, 2026Open on DART
  • [Amended] Small-Scale Public Offering Results Report[기재정정]소액공모실적보고서

    Predicted impact: Low

    Oct 29, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)

    Predicted impact: Low

    Oct 29, 2026Open on DART
  • Lawsuit filed or ruled소송등의제기ㆍ신청(경영권분쟁소송) (신주발행금지가처분)

    Predicted impact: Medium

    New lawsuit filing by a small biotech; claim size and details not given.

    Oct 28, 2026Open on DART
  • Lawsuit filed or ruled주요사항보고서(소송등의제기)

    Predicted impact: Medium

    New lawsuit filing by a small biotech; claim size and details not given.

    Oct 28, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의 (임시주주총회)

    Predicted impact: Low

    Oct 21, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류

    Predicted impact: Low

    Oct 21, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고

    Predicted impact: Low

    Oct 21, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)

    Predicted impact: Low· Actual: −7.6% vs sector, volume 0.1× normal (5 trading days)

    Issuance results repeat the rights offering already amended in the last 14 days.

    Oct 14, 2026Open on DART
  • Small Public Offering Performance Report소액공모실적보고서

    Predicted impact: Low· Actual: −7.6% vs sector, volume 0.1× normal (5 trading days)

    Small public offering report repeats the amended rights offering already reported.

    Oct 14, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)

    Predicted impact: Low· Actual: −7.6% vs sector, volume 0.1× normal (5 trading days)

    Oct 14, 2026Open on DART
  • Small-Scale Public Offering Disclosure Documents (Equity Securities)소액공모공시서류(지분증권)Oct 2, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Oct 2, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Sep 22, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 22, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Sep 22, 2026Open on DART
  • Entry into Agreement on Change of Management Control경영권변경등에관한계약체결Sep 21, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Sep 21, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의 (임시주주총회)Sep 21, 2026Open on DART
  • Lawsuit filed or ruled소송등의판결ㆍ결정(일정금액이상의청구)Aug 14, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (사업반환청구의 소 제기의 건)Aug 13, 2026Open on DART
  • Amended: Lawsuit filed or ruled[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)Aug 6, 2026Open on DART
  • Lawsuit filed or ruled소송등의판결ㆍ결정(일정금액이상의청구)Aug 5, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 14, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 9, 2026Open on DART
  • Decision to Provide Collateral for Third Party타인에대한담보제공결정Jul 7, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jul 7, 2026Open on DART
  • [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Jul 7, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 1, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 30, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (COVID-19 예방 백신 AdCLD-CoV19-1 OMI의 제3상 임상시험 결과)Jun 26, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (사업반환청구의 소 제기의 건)Jun 25, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과May 22, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고May 22, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 20, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (COVID-19 예방 백신 AdCLD-CoV19-1 LP.8.1의 제2상 임상시험 계획 승인(IND) 신청 반려)May 8, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 6, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Cellid / 셀리드 / 299660 / KRX:299660

Source: KRX statistical information